Top Markets
Coin of the day
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
Hisse Senetlerindeki Sıralama #25842
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
Hisse Fiyatı
$0.40861751
Piyasa Değeri
$45.81M
Değişim (1 gün)
-1.15%
Değişim (1 yıl)
-46.41%
Ülke
TW
Ticaret TaiRx, Inc. (6580)

Kategori

TaiRx, Inc. (6580) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.42 - 2026-08-01

Gün sonu en düşük fiyat: $1.41 - 2017-06-01
TaiRx, Inc. için hisse fiyatı geçmişi: 2017 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -13.06%
2025 -14.32%
2024 -0.12%
2023 -32.09%
2022 -18.00%
2021 52.04%
2020 57.15%
2019 -14.81%
2018 -18.47%
2017 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$539.14 36.71%
US
$1.04K 56.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$130.43 385.07%
US